EMEA-002393-PIP01-18

Key facts

Active substance
Cell-free solution of lysed Escherichia coli culture, strain Laves
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0328/2018
PIP number
EMEA-002393-PIP01-18
Pharmaceutical form(s)
Oral solution
Condition(s) / indication(s)
Treatment of irritable bowel syndrome, treatment of colitis (excluding infective)
Route(s) of administration
Oral use
Contact for public enquiries
Laves-Arzneimittel GmbH

Tel. +49 511438740
E-mail: info@laves-pharma.de

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating